Large B cell non-hodgkin’s lymphoma: Optimising therapy for elderly patients

Comparing various prognostic scores used to predict outcomes in elderly patients with DLBCL

REDLAMP 2: Characteristics, Treatment, Prognosis, Outcomes, Mortality in Elderly Follicular Lymphoma

Why is an elderly prognostic index required for patients with DLBCL?

BCEEEF 2011: Treatment of elderly non-Hodgkin's lymphoma patients.

Current treatment options for older patients with DLBCL

Management of older adults with mantle-cell lymphoma

Hodgkin Lymphoma: Addressing the Elderly Population

Dr. Smith Discusses Lymphoma in the Elderly

REDLAMP 8: Does a Geriatric Assessment Hold Prognostic Value for Patients with Aggressive NHL?

Management and outcomes of elderly patients with LBCL

Elderly DLBCL updates

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diff...

CAR-T is Feasible in B-Cell Lymphoma Patients Over 80 Years Old | Julio Chavez, MD | EHA 2024

Addressing under-representation of elderly patients in DLBCL clinical trials

Dr. Goy Discusses the Treatment of Elderly Patients With Lymphoma

Unmet needs in LBCL: treatment options for elderly or frail patients

Challenges Facing the Management of Hodgkin's Lymphoma in Elderly Patients

A question of age: how should elderly DLBCL patients be treated?

DLBCL Prognosis & Management in Front-line Settings #oncology #lungcancer #cancer #2023